Lisa Nyberg
Hepatology · San Diego, CANPI 1215085121
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,850 of the $3,178 with a category attached, or 89.7%. Gilead accounts for 97.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2020 at $2,850 and has fallen 94.4% since, to $161 in 2024. That places this record below the midpoint for hepatology clinicians in CA, where the typical reported total is $4,366.
Across 5 payments — averaging $635.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$3K
- Biocompatibles, Inc.$68
Across 18 payments — averaging $50,016 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$865K
- AbbVie$35K
- Merck$194
What the payments were for
- Consulting fees$2,85090%
- Food & beverage$32810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 4 | $3,110 |
| Biocompatibles, Inc. | 1 | $68 |
How this compares
$3,178 in reported general payments places this provider in the 45th percentile of 36 hepatology providers in California.
Other hepatology in San Diego
- Yuko KonoSan Diego$16K
- Robert GishFolsom$1.9M
- Edward MenaPasadena$624K
- Walid AyoubWest Hollywood$416K
- Tarek HassaneinCoronado$278K
- Ke-Qin HuOrange$239K
- Vinay SundaramLos Angeles$203K
- Marina RoytmanFresno$165K
- Adam Deisingla Jolla$131K
- Maurizio BonaciniSan Francisco$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.